Almag-03 Diamag — Transcranial Magnetic Stimulation for Neurological Relief
Overview
Non-invasive TMS/PEMF device for migraine relief, stroke recovery support, sleep disorders, Parkinson’s symptoms, and mood regulation. Home-use capable. Protocol-driven programs. No special medical training required.
Supportive Use
Targeted pulsed magnetic fields modulate cortical excitability, improve regional blood flow, and support neural repair. Daily sessions reduce pain, normalize sleep, and aid motor control. Use in cycles per protocol.
What’s Included
• Almag-03 Diamag control unit
• Head/occipital radiator with inductors
• Power supply and cables
• Instruction manual with indications, contraindications, and protocols
Materials & Features
• Preset programs for migraine, post-stroke rehab, Parkinson’s, and sleep disorders
• Once-daily sessions; cycle length 7–20 days; repeat after 1.5–2 months per protocol
• Ergonomic head applicators; audible end-of-session alert
• For home or clinic use
Research & Clinical Trials
• MBUZ GKB No. 31 (Moscow) — clinical base of the Scientific Research Institute of Cerebrovascular Disease and Stroke: efficacy and safety in acute stroke phase
• City Hospital No. 4 (Vladimir) — feasibility for stroke, migraine, and sleep disorders
• Resorts “Solotcha” (RyazGMU Medical University) — clinical efficacy in Parkinson’s rehabilitation, post-stroke recovery, and chronic iridocyclitis
• Device used within standard care pathways for stroke in cited settings
Note: Consult a licensed clinician before starting or modifying therapy. Device is not a substitute for emergency or primary medical care.
Indications (TMS/PEMF)
• Migraine and migraine neuralgia
• Sleep disturbances
• Effects of cerebrovascular accident (acute/subacute and sequelae)
• Transient ischemic attack
• Chronic cerebral ischemia
• Parkinson’s disease
• Chronic iridocyclitis
• Cervical osteochondrosis with cranialgia/cephalgia
Contraindications
• Pregnancy
• Pacemaker or implanted electronic devices
• Cardiac/aortic/large-vessel aneurysm
• Cardiac arrhythmias
• Systemic blood diseases, thrombocytopenia/coagulopathy/bleeding tendency
• Malignant neoplasms
• Active tuberculosis
• Acute infectious diseases; fever
• Hyperthyroidism
• Respiratory failure
• Alcohol/acute mental excitation
• Acute purulent processes of the head
Technical Characteristics of Individual Brain Treatments (positioning, program, cadence)
General cadence: once daily; max 20 consecutive days; repeat after 1.5–2 months.
• Migraine / Migraine neuralgia: Radiator cable at occiput; extreme inductors on forehead. Program 1 for 7–10 days, then Program 2 for 7–10 days.
• Transient ischemic attack / Post-CVA effects / Chronic cerebral ischemia: Same positioning as above. Program 1 then Program 2, 7–10 days each, up to 20 days total.
• Sleep disorders: Same positioning; Program 1; up to 20 days.
• Parkinson’s disease: Same positioning; Program 4; up to 20 days.
• Chronic iridocyclitis: Cable at occiput; extreme inductors over eyes; remaining inductors near ear edges. Program 3; up to 20 days.
Dimensions
Compact tabletop control unit with lightweight head applicators.
Technical Specifications
• Device type: TMS/PEMF system
• Programs: preset therapeutic programs (per above)
• Session length: protocol-defined; 7–20 days per cycle, once daily
• Power: 110–240 V AC
• Operation: menu-driven; Start/Stop button; audible end signal
Warranty
Full manufacturer guarantee. Service and maintenance support included.
Shipping
Processing 0–5 business days. Typical delivery within 20 days of order confirmation.
Assembly & Use
-
Connect device to power.
-
Select program.
-
Position applicators per protocol.
-
Press Start/Stop.
-
End signal indicates completion; power down.
Medical disclaimer: For informational purposes only. Not medical advice. Follow contraindications and consult your clinician for individualized use.